RE:RE:RE:Here you goEyeDontBelieveU wrote: trivela wrote:
What the heck! A 7.2 multiple! Why not a 6.95, or 7.15, or even a 7.05 multiple! Shorts are salivating with this kind of "research"! This is a typical half full/half empty glass scenario. Let me just remind that the first debt maturity is the bank debt (dollar and pound) and it is .... in 2021. So we have to wait for 2017, 2018, 2019 and 2020 to see if the company will default .... At this point, I believe they have a decent chance of turning things around.
Wrong. Coupon on the 9.5 notes is due in a few days. The 2nd earn out payment is due in two weeks. The bridge loan is due in Oct 2017 or the interest rate jumps to 11%
Oh and I didn't mention the coupon payments due on the other 7% notes or the first lien notes.
They have to service the debt. That is what the shorts do not think will be possible with the declining revenues from their drug portfolio and the potential CMA fines and regulatory risk of Donnatal.